The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: A pilot study

Diabetic Medicine

Volumn 20, Issue 3, 2003, Pages 231-237

  Bingham, Emma ^a   Hopkins, D ^a   Pernet, A ^a   Reid, H ^a   Macdonald, I A ^b   Amiel, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Cognitive function; Diazoxide; Glibenclamide; Hypoglycaemia; Sulphonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; GLIBENCLAMIDE; GLUCOSE; HUMAN ACTRAPID; INSULIN; PLACEBO; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHANNEL GATING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN INFUSION; MALE; NERVE CELL; PANCREAS ISLET BETA CELL; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADENOSINE TRIPHOSPHATE; ADULT; BLOOD GLUCOSE; COGNITION; DIABETES MELLITUS; DIAZOXIDE; GLUCOSE CLAMP TECHNIQUE; GLYBURIDE; HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; PILOT PROJECTS; POTASSIUM CHANNELS; VASODILATOR AGENTS;

EID: 0037352518     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00922.x     Document Type: Article

References (35)

1. Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long acting versus short acting sulphonylureas. Diabet Med 1999; 16: 586-590.
2. Peacey SR, George E, Rostami-Hudjegan A, Bedford C, Harris N, Hardisty CA et al. Similar physiological and symptomatic response to sulphonylurea and insulin induced hypoglycaemia in normal subjects. Diabet Med 1996; 13: 634-641.
3. Asplund K, Wiholm BE, Lithner F. Glibenclamide associated hypoglycaemia: a report on 57 cases. Diabetalogia 1983; 6: 412-417.
4. UK Prospective Diabetes Study Group (UKPDS 33). Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-853.
5. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald IA et al. Effects of glycemic control on protective responses against hypoglycaemia in type 2 diabetes mellitus. Diabetes Care 1998; 21: 282-291.
6. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA. Delay in onset of awareness of acute hypoglycaemia and of restoration of cognitive performance during recovery. Diabetes Care 2000; 23: 893-897.
7. Lee K, Dixon AK, Richardson PJ, Pinnock RD. Glucose receptive neurones in the rat ventromedial hypothalamus express KATP channels composed of Kir 6.1 and SUR1 subunits. J Physiol 1999; 515: 439-452.
8. Lynon RM, Tompkins S, Brooks HL, Dunn-Meynell AD, Levin BE. Localisation of glucokinase gene expression in the rat brain. Diabetes 2000; 49: 695-700.
9. Yang X-J, Kow L-M, Funabashi T, Mobbs CV. Hypothalamic glucose sensor. Similarities to and differences from pancreatic beta cell mechanisms. Diabetes 1999; 48: 1763-1772.
10. Ashford MLJ, Boden PR, Treherne JM. Glucose induced excitation of hypothalamic neurones is mediated by ATP sensitive K+ channels. Eur J Physiol 1990; 15: 479-483.
11. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-223.
12. Liu D, Moberg E, Kollind K, Lins PE, MacDonald IA. Arterial, arterialised venous, venous capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992; 35: 287-290.
13. Amiel SA, Simonsen DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycaemia in normal and diabetic humans. Diabetes 1987; 36: 518-522.
14. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 1993; 10: 231-237.
15. Frier BM, Fisher BM, eds. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. London: Edward Arnold: 93-103.
16. Wilkinson RT, Houghton D. Portable four-choice reaction time test with magnetic tape memory. Behav Res Meth Instrument 1975; 7: 441-446.
17. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycaemia. Proc Natl Acad Sci USA 1994; 91: 9352-9356.
18. Heller SR, MacDonald IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 1996; 13: 607-615.
19. Stroop J. Studies of interference in serial verbal reaction. J Exp Psychol 1935; 18: 643-622.
20. Jensen AR, Rohwer WD Jr. The Stroop colour-word test - a review. Acta Psychol 1966; 25: 36-93.
21. Macdonald IA, Lake DM. An improved method for extracting catecholamines from body fluids. J Neurosci Meth 1985; 13: 239-248.
22. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively treated insulin dependent diabetes mellitus. Diabetologia 1995; 38: 1412-1418.
23. Rosenthal JM, Amiel SA, Yaguez L, Bullmore E, Hopkins D, Evans M et al. The effect of acute hypoglycaemia on brain function and activation. Diabetes 2001; 50: 1618-1626.
24. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37: 901-907.
25. Takanaga H, Murakami H, Matsuo H, Naito M, Tsuruo T, Sawada Y. Efflux transport of tolbutamide across the blood brain barrier. J Pharm Pharmacol 1998; 50: 1027-1033.
26. Hensley IE, Lawler JE, Almzadeh R, Holshouser SJ. Diazoxide effects on hypothalamic and extra-hypothalamic NPY content in Zucker rats. Peptides 2001; 22: 899-908.
27. Ferrranini E, Galvan AQ, Gastaldelli A, Camastra S, Sirioni AM, Toschi E et al. Insulin: new roles for an ancient hormone. Eur J Clin Invest 1999; 10: 842-852.
28. Clarke DW, Mudd L, Boyd FT, Fields M, Raizada MK. Insulin is released from rat brain neuronal cells in culture. J Neurochem 1986; 47: 831-836.
29. Kern W, Kerner W, Pietrowsky R, Fehm HL, Born J. Effects of insulin and hypoglycaemia on the auditory brain stem response in humans. J Neurophysiol 1994; 72: 678-683.
30. Kern W, Schlosser C, Kerner W, Pietrowsky R, Born J, Fehm HL. Evidence for effects of insulin on sensory processing in humans. Diabetes 1994; 43: 351-356.
31. Horinka N, Kuang TY, Pak H, Wang R, Jehle J, Kennedy C et al. Blockade of cerebral blood flow response to insulin induced hypoglycaemia by caffeine and glibenclamide in conscious rats. 1997; 17: 1309-1318.
32. Faraci FM, Sobey CG. Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab 1998; 18: 1047-1063.
33. Feldman JM. Glyburide: a second-generation sulphonylurea hypoglycaemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy 1985; 5: 43-46.
34. Dollery C. Diazoxide. In Therapeutic Drugs, Vol. 1. 1991.
35. Landstedt-Hallin L, Adamson U, Lins PE. Oral glibenclamide suppresses glucagon secretion during insulin induced hypoglycaemia in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 3140-3145.